Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
|
+$629M |
| 2 |
AGN
Allergan plc
AGN
|
+$463M |
| 3 |
State Street SPDR S&P Aerospace & Defense ETF
XAR
|
+$350M |
| 4 |
iShares Biotechnology ETF
IBB
|
+$315M |
| 5 |
BPL
Buckeye Partners, L.P.
BPL
|
+$265M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$978M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$675M |
| 3 |
Apple
AAPL
|
+$429M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$387M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$344M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 7.7% |
| 2 | Healthcare | 5.71% |
| 3 | Financials | 4.62% |
| 4 | Consumer Discretionary | 4.5% |
| 5 | Communication Services | 3.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
ESPR
5326
PUT
DELISTED
Esperion Therapeutics
ESPR
| $106K | ﹤0.01% |
2,900
| – | – |
|
5327
First Internet Bancorp
INBK
$257M
| $106K | ﹤0.01% |
4,975
-1,534
| -24% | -$31.5K |
|
5328
CALL
Nu Skin
NUS
$252M
| $106K | ﹤0.01% |
2,500
+900
| +56% | +$37.8K |
|
5329
PUT
Travel + Leisure Co
TNL
$4.66B
| $106K | ﹤0.01% |
2,300
-400
| -15% | -$17.9K |
|
|
CMLS
5330
DELISTED
Cumulus Media Inc. Class A Common Stock
CMLS
| $106K | ﹤0.01% |
7,298
-2,142
| -23% | -$32.2K |
|
|
SWI
5331
DELISTED
SolarWinds Corporation Common Stock
SWI
| $106K | ﹤0.01% |
5,453
-32,509
| -86% | -$618K |
|
5332
DHI Group
DHX
$182M
| $105K | ﹤0.01% |
27,053
-24,116
| -47% | -$89.5K |
|
5333
Elbit Systems
ESLT
$37.9B
| $105K | ﹤0.01% |
637
+454
| +248% | +$71.5K |
|
5334
Forestar Group
FOR
$1.44B
| $105K | ﹤0.01% |
5,757
-1,473
| -20% | -$28.9K |
|
5335
Merchants Bancorp
MBIN
$2.53B
| $105K | ﹤0.01% |
9,590
-16,467
| -63% | -$183K |
|
5336
Spyre Therapeutics
SYRE
$8.54B
| $105K | ﹤0.01% |
545
-143
| -21% | -$27.9K |
|
|
GNC
5337
PUT
DELISTED
GNC Holdings, Inc.
GNC
| $105K | ﹤0.01% |
49,100
+19,800
| +68% | +$39.6K |
|
5338
Dianthus Therapeutics
DNTH
$5.84B
| $104K | ﹤0.01% |
633
-392
| -38% | -$74.5K |
|
5339
CALL
Edgewell Personal Care
EPC
$1.25B
| $104K | ﹤0.01% |
3,200
+2,000
| +167% | +$59.7K |
|
5340
Hurco Companies Inc
HURC
$135M
| $104K | ﹤0.01% |
3,228
-995
| -24% | -$33.2K |
|
5341
Interactive Brokers
IBKR
$39.2B
| $104K | ﹤0.01% |
7,732
-81,408
| -91% | -$1.01M |
|
5342
CALL
iShares Russell 1000 Value ETF
IWD
$82.2B
| $103K | ﹤0.01% |
+800
| New | +$102K |
|
5343
Noodles & Co
NDLS
$111M
| $103K | ﹤0.01% |
2,274
-27
| -1% | -$1.45K |
|
|
PLYA
5344
DELISTED
Playa Hotels & Resorts
PLYA
| $103K | ﹤0.01% |
13,181
+111
| +0.8% | +$850 |
|
5345
Reading International Class A
RDI
$33.2M
| $103K | ﹤0.01% |
8,554
-3,958
| -32% | -$50K |
|
5346
CALL
Webster Financial
WBS
$12.5B
| $103K | ﹤0.01% |
2,200
| – | – |
|
5347
PUT
Coeur Mining
CDE
$15.4B
| $102K | ﹤0.01% |
21,200
+20,700
| +4,140% | +$103K |
|
5348
First Business Financial Services
FBIZ
$587M
| $102K | ﹤0.01% |
4,222
-1,343
| -24% | -$31.6K |
|
5349
PUT
Henry Schein
HSIC
$9.77B
| $102K | ﹤0.01% |
1,600
+400
| +33% | +$25.8K |
|
5350
iShares Core S&P Mid-Cap ETF
IJH
$122B
| $102K | ﹤0.01% |
2,650
-70
| -3% | -$2.69K |
|
Similar funds
Barclays's Q3 2019 Portfolio in Review
As of Q3 2019, Barclays held 7,551 positions worth $160B, down 2.1% from $163B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Barclays's Q3 2019 filing shows 501 new, 2,626 increased, 3,452 reduced and 568 closed positions. Its largest new stake was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $978M.
By sector, the portfolio is most concentrated in Technology at 7.7% of assets, down from 8.5% a quarter earlier, followed by Healthcare and Financials.
- Barclays's largest Q3 2019 buy was State Street SPDR S&P Aerospace & Defense ETF: 3,300,000 shares worth $353M.
- Barclays added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q3 2019, an estimated $629M increase.
- Barclays's biggest Q3 2019 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $978M.
- Barclays fully exited Anadarko Petroleum in Q3 2019, selling an estimated $309M.
- Barclays's ten largest holdings make up 28% of its $160B portfolio in Q3 2019.
- Barclays opened 501 new positions and closed 568 in Q3 2019.
- Barclays's portfolio value fell 2.1% quarter-over-quarter to $160B.
Based on Barclays's 13F filing for Q3 2019, filed 14 Nov 2019.